• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchGenenta Science SpA
    Picture of Genenta Science SpA logo

    GNTA — Genenta Science SpA News Story

    $1.810.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $42.41m
    • Enterprise Value
      $19.02m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • GNTA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    GNTA Dividends
    All News

    NASDAQ RESUMED AT 10:18 AM

    Picture of Genenta Science SpA logoGenenta Science SpA
    28/06/2022 15:18
    NASDAQ RESUMED  GNTA.O  AT 10:18 AM
    

    Recent news on Genenta Science SpA

    See all news
    • Brief: Genenta & Anemocyte Announce Strategic Partnership To Advance Off-The-Shelf LVV Plasmid Dna Production

      24/10/2025 09:33
    • Brief: Genenta Science SpA -Entered Amendment To ATM Sales Agreement Dated April 26

      20/12/2024 21:50
    • Brief: Genenta To Provide Update On Lead Product Temferon™

      16/05/2023 12:06
    • Genenta Science rises on FDA's "orphan drug" tag for brain cancer drug

      02/03/2023 16:31
    • Brief: FDA Grants Orphan Drug Designation To Brain Cancer Treatment

      02/03/2023 12:56

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.